EnglishFrenchGermanItalianRussianSpanish

Resource Library

rfxcel Acquires Frequentz Assets

rfxcel, the world’s leader in supply chain track and trace for the Pharmaceutical industry is pleased to announce the acquisition of assets from Frequentz, Inc., a leading player in life science

Patient Safety Through Traceability

Global pharmaceutical safety through smart serialization and open collaboration. The need for pharmaceutical companies to have absolute and accurate visibility of their supply chains is imperative.

rfxcel Drives EU Expansion with Industry Experts

rfxcel will expand its capability to enable Life Sciences companies to meet serialization and regulatory compliance needs in the European territories.

RFXCEL RAISES $30 MILLION IN SERIES B FINANCING.

August 3, 2017: rfXcel, the leader in Track and Trace and regulatory compliance solutions, today announces it has raised $30 million in a round of funding led by Kayne Partners. Kayne Partners is the

rfXcel Announces Promotion of Brian Bilyeu to Vice

January 4, 2017: rfXcel the leader in serialization, traceability, and DSCSA and global compliance for the Pharmaceutical and Life Sciences industries, today announced the promotion of Brian Bilyeu

rfXcel and Be4ward Announce a Webinar to Address the

November 2, 2016: rfXcel and Be4ward announce that they will co-host an informative webinar on November 16, 2016 for Contract Manufactures. This session will help clarify some of the confusion

rfXcel Awarded Group Purchasing Agreement with Premier to

July 26, 2016: rfXcel SNAP product will be made available to all Premier members at preferred pricing
San Ramon, Calif. & Charlotte, N.C., July 26, 2016 – rfXcel, the leader in

rfxcel’s Successful Partnership with Verizon

Verizon Extends Healthcare Focus to Pharmaceutical Sector with rfxcel

rfxcel Releases a New Traceability Solution

January 20, 2017: rfxcel Transforms Global Compliance and Serialization with Release of Next Generation Platform

FDA Delays DSCSA Implementation for 2018

June 30, 2017: FDA Delays Enforcement of DSCSA Transaction Information until Nov 26, 2018